Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Safety and cost benefit of an accelerated infliximab infusion protocol in the treatment of ambulatory patients with inflammatory bowel diseases.

Authors
  • Saxena, Payal
  • Chen, Guang
  • Jideh, Bilel
  • Collins, Glen
  • Leong, Rupert W
Type
Published Article
Journal
Expert Opinion on Biological Therapy
Publisher
Informa UK (Ashley Publications)
Publication Date
Mar 01, 2014
Volume
14
Issue
3
Pages
277–282
Identifiers
DOI: 10.1517/14712598.2014.866649
PMID: 24359522
Source
Medline
License
Unknown

Abstract

Accelerated 30-min infliximab infusions significantly reduced nursing time, cost and increased patient satisfaction without increasing infusion reactions. Increased patient freedom and improved efficiency in healthcare delivery can be expected.

Report this publication

Statistics

Seen <100 times